Sapient is a leader in multi-omics data generation and insight delivery, providing bespoke services for proteomics, metabolomics, and lipidomics that enable biopharma sponsors to go beyond the genome to accelerate precision drug development. Utilizing cutting-edge, high throughput mass spectrometry, we make nontargeted and targeted measurements to capture thousands of dynamic biomarkers – including proteins, metabolites, and lipids – per sample, across thousands of samples at a time. We pair this with advanced biocomputational frameworks enabling comprehensive biomarker-phenotype mapping for discovery of robust biomarkers, drug targets, and clinical signatures of drug response. Aided by our DynamiQ™ Insights Engine — a longitudinal database of integrated multi-omics and real-world data collected in tens of thousands of samples — we can support rapid drug target identification, biomarker discovery and validation, and translational insights across all stages of drug development, including clinical trials.